Canada markets closed

Kazia Therapeutics Limited (KZIA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2720-0.0105 (-3.72%)
At close: 04:00PM EDT
0.2710 -0.00 (-0.37%)
After hours: 05:31PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.17M
Enterprise Value 5.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.08
Enterprise Value/Revenue -1.34k
Enterprise Value/EBITDA -0.29

Trading Information

Stock Price History

Beta (5Y Monthly) 2.11
52-Week Change 3-77.24%
S&P500 52-Week Change 322.38%
52 Week High 31.3900
52 Week Low 30.1900
50-Day Moving Average 30.3042
200-Day Moving Average 30.5769

Share Statistics

Avg Vol (3 month) 3847.16k
Avg Vol (10 day) 3214.64k
Shares Outstanding 526.36M
Implied Shares Outstanding 623.63M
Float 8219M
% Held by Insiders 10.00%
% Held by Institutions 118.68%
Shares Short (Apr 15, 2024) 418.34k
Short Ratio (Apr 15, 2024) 40.03
Short % of Float (Apr 15, 2024) 4N/A
Short % of Shares Outstanding (Apr 15, 2024) 40.07%
Shares Short (prior month Mar 15, 2024) 4242.79k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 14, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jul 14, 2017

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-148,056,737.50%

Management Effectiveness

Return on Assets (ttm)-46.42%
Return on Equity (ttm)-186.37%

Income Statement

Revenue (ttm)560
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -17.52M
Net Income Avi to Common (ttm)-15.7M
Diluted EPS (ttm)-0.3600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.56M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)359.3k
Total Debt/Equity (mrq)6.82%
Current Ratio (mrq)0.71
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-12.68M
Levered Free Cash Flow (ttm)-6.57M